AstraZeneca just paused its COVID-19 vaccine trial, and that’s a good thing
AstraZeneca’s coronavirus vaccine, which was first developed by researchers at the University of Oxford before partnering with the pharmaceutical giant, is currently among the world’s most promising candidates. (Unsplash/)As the pandemic continues to rage across the United States and around the world, researchers have become laser-focused on creating a vaccine effective against COVID-19. There are now several candidates in late-stage clinical trials and every step is being scrutinized by not only the researchers but the entire world. Yesterday afternoon, pharmaceutical giant AstraZeneca announced its plan to voluntarily halt the combined Phase 2/3 trial for their COVID-19 vaccine candidate due to a suspected adverse reaction in a patient who participated in the trial in the UK, according to STAT.AstraZeneca’s coronavirus vaccine, which was first developed by researchers at the University of Oxford, is currently among the world’s most promising candidates. The company said in two statements yesterday that people involved with...